Solvency ratios also known as long-term debt ratios measure a company ability to meet long-term obligations.
Solvency Ratios (Summary)
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
Solvency ratio | Description | The company |
---|---|---|
Debt to equity ratio | A solvency ratio calculated as total debt divided by total shareholders’ equity. | |
Debt to equity ratio (including operating lease liability) | A solvency ratio calculated as total debt (including operating lease liability) divided by total shareholders’ equity. | Intuitive Surgical Inc. debt to equity ratio (including operating lease liability) improved from 2022 to 2023 but then deteriorated significantly from 2023 to 2024. |
Debt to capital ratio | A solvency ratio calculated as total debt divided by total debt plus shareholders’ equity. | |
Debt to capital ratio (including operating lease liability) | A solvency ratio calculated as total debt (including operating lease liability) divided by total debt (including operating lease liability) plus shareholders’ equity. | Intuitive Surgical Inc. debt to capital ratio (including operating lease liability) improved from 2022 to 2023 but then deteriorated significantly from 2023 to 2024. |
Debt to assets ratio | A solvency ratio calculated as total debt divided by total assets. | |
Debt to assets ratio (including operating lease liability) | A solvency ratio calculated as total debt (including operating lease liability) divided by total assets. | Intuitive Surgical Inc. debt to assets ratio (including operating lease liability) improved from 2022 to 2023 but then deteriorated significantly from 2023 to 2024. |
Financial leverage ratio | A solvency ratio calculated as total assets divided by total shareholders’ equity. | Intuitive Surgical Inc. financial leverage ratio decreased from 2022 to 2023 and from 2023 to 2024. |
Solvency ratio | Description | The company |
---|---|---|
Fixed charge coverage ratio | A solvency ratio calculated as earnings before fixed charges and tax divided by fixed charges. | Intuitive Surgical Inc. fixed charge coverage ratio improved from 2022 to 2023 and from 2023 to 2024. |
Debt to Equity
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Selected Financial Data (US$ in thousands) | ||||||
Total debt | —) | —) | —) | —) | —) | |
Total Intuitive Surgical, Inc. stockholders’ equity | 16,433,700) | 13,307,600) | 11,041,900) | 11,901,100) | 9,731,500) | |
Solvency Ratio | ||||||
Debt to equity1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Benchmarks | ||||||
Debt to Equity, Competitors2 | ||||||
Abbott Laboratories | — | 0.38 | 0.46 | 0.50 | 0.57 | |
Cigna Group | — | 0.67 | 0.69 | 0.71 | 0.65 | |
CVS Health Corp. | — | 0.81 | 0.74 | 0.75 | 0.93 | |
Elevance Health Inc. | — | 0.64 | 0.66 | 0.64 | 0.60 | |
Medtronic PLC | 0.50 | 0.47 | 0.46 | 0.51 | 0.49 | |
UnitedHealth Group Inc. | — | 0.70 | 0.74 | 0.64 | 0.66 | |
Debt to Equity, Sector | ||||||
Health Care Equipment & Services | — | 0.62 | 0.62 | 0.62 | 0.66 | |
Debt to Equity, Industry | ||||||
Health Care | — | 0.81 | 0.72 | 0.79 | 0.90 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
Debt to equity = Total debt ÷ Total Intuitive Surgical, Inc. stockholders’ equity
= 0 ÷ 16,433,700 = 0.00
2 Click competitor name to see calculations.
Solvency ratio | Description | The company |
---|---|---|
Debt to equity ratio | A solvency ratio calculated as total debt divided by total shareholders’ equity. |
Debt to Equity (including Operating Lease Liability)
Intuitive Surgical Inc., debt to equity (including operating lease liability) calculation, comparison to benchmarks
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Selected Financial Data (US$ in thousands) | ||||||
Total debt | —) | —) | —) | —) | —) | |
Operating lease liabilities (reported as Other accrued liabilities) | 33,500) | 25,300) | 24,200) | 20,400) | 21,900) | |
Operating lease liabilities (reported as Other long-term liabilities) | 112,500) | 64,500) | 69,600) | 66,600) | 58,000) | |
Total debt (including operating lease liability) | 146,000) | 89,800) | 93,800) | 87,000) | 79,900) | |
Total Intuitive Surgical, Inc. stockholders’ equity | 16,433,700) | 13,307,600) | 11,041,900) | 11,901,100) | 9,731,500) | |
Solvency Ratio | ||||||
Debt to equity (including operating lease liability)1 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Benchmarks | ||||||
Debt to Equity (including Operating Lease Liability), Competitors2 | ||||||
Abbott Laboratories | — | 0.41 | 0.49 | 0.54 | 0.61 | |
Cigna Group | — | 0.68 | 0.70 | 0.73 | 0.67 | |
CVS Health Corp. | — | 1.04 | 1.00 | 1.01 | 1.23 | |
Elevance Health Inc. | — | 0.66 | 0.69 | 0.67 | 0.63 | |
Medtronic PLC | 0.52 | 0.49 | 0.48 | 0.53 | 0.51 | |
UnitedHealth Group Inc. | — | 0.76 | 0.80 | 0.70 | 0.73 | |
Debt to Equity (including Operating Lease Liability), Sector | ||||||
Health Care Equipment & Services | — | 0.69 | 0.70 | 0.70 | 0.75 | |
Debt to Equity (including Operating Lease Liability), Industry | ||||||
Health Care | — | 0.86 | 0.78 | 0.84 | 0.96 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
Debt to equity (including operating lease liability) = Total debt (including operating lease liability) ÷ Total Intuitive Surgical, Inc. stockholders’ equity
= 146,000 ÷ 16,433,700 = 0.01
2 Click competitor name to see calculations.
Solvency ratio | Description | The company |
---|---|---|
Debt to equity ratio (including operating lease liability) | A solvency ratio calculated as total debt (including operating lease liability) divided by total shareholders’ equity. | Intuitive Surgical Inc. debt to equity ratio (including operating lease liability) improved from 2022 to 2023 but then deteriorated significantly from 2023 to 2024. |
Debt to Capital
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Selected Financial Data (US$ in thousands) | ||||||
Total debt | —) | —) | —) | —) | —) | |
Total Intuitive Surgical, Inc. stockholders’ equity | 16,433,700) | 13,307,600) | 11,041,900) | 11,901,100) | 9,731,500) | |
Total capital | 16,433,700) | 13,307,600) | 11,041,900) | 11,901,100) | 9,731,500) | |
Solvency Ratio | ||||||
Debt to capital1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Benchmarks | ||||||
Debt to Capital, Competitors2 | ||||||
Abbott Laboratories | — | 0.28 | 0.31 | 0.34 | 0.36 | |
Cigna Group | — | 0.40 | 0.41 | 0.42 | 0.40 | |
CVS Health Corp. | — | 0.45 | 0.42 | 0.43 | 0.48 | |
Elevance Health Inc. | — | 0.39 | 0.40 | 0.39 | 0.38 | |
Medtronic PLC | 0.33 | 0.32 | 0.31 | 0.34 | 0.33 | |
UnitedHealth Group Inc. | — | 0.41 | 0.43 | 0.39 | 0.40 | |
Debt to Capital, Sector | ||||||
Health Care Equipment & Services | — | 0.38 | 0.38 | 0.38 | 0.40 | |
Debt to Capital, Industry | ||||||
Health Care | — | 0.45 | 0.42 | 0.44 | 0.47 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
Debt to capital = Total debt ÷ Total capital
= 0 ÷ 16,433,700 = 0.00
2 Click competitor name to see calculations.
Solvency ratio | Description | The company |
---|---|---|
Debt to capital ratio | A solvency ratio calculated as total debt divided by total debt plus shareholders’ equity. |
Debt to Capital (including Operating Lease Liability)
Intuitive Surgical Inc., debt to capital (including operating lease liability) calculation, comparison to benchmarks
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Selected Financial Data (US$ in thousands) | ||||||
Total debt | —) | —) | —) | —) | —) | |
Operating lease liabilities (reported as Other accrued liabilities) | 33,500) | 25,300) | 24,200) | 20,400) | 21,900) | |
Operating lease liabilities (reported as Other long-term liabilities) | 112,500) | 64,500) | 69,600) | 66,600) | 58,000) | |
Total debt (including operating lease liability) | 146,000) | 89,800) | 93,800) | 87,000) | 79,900) | |
Total Intuitive Surgical, Inc. stockholders’ equity | 16,433,700) | 13,307,600) | 11,041,900) | 11,901,100) | 9,731,500) | |
Total capital (including operating lease liability) | 16,579,700) | 13,397,400) | 11,135,700) | 11,988,100) | 9,811,400) | |
Solvency Ratio | ||||||
Debt to capital (including operating lease liability)1 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Benchmarks | ||||||
Debt to Capital (including Operating Lease Liability), Competitors2 | ||||||
Abbott Laboratories | — | 0.29 | 0.33 | 0.35 | 0.38 | |
Cigna Group | — | 0.40 | 0.41 | 0.42 | 0.40 | |
CVS Health Corp. | — | 0.51 | 0.50 | 0.50 | 0.55 | |
Elevance Health Inc. | — | 0.40 | 0.41 | 0.40 | 0.39 | |
Medtronic PLC | 0.34 | 0.33 | 0.32 | 0.35 | 0.34 | |
UnitedHealth Group Inc. | — | 0.43 | 0.45 | 0.41 | 0.42 | |
Debt to Capital (including Operating Lease Liability), Sector | ||||||
Health Care Equipment & Services | — | 0.41 | 0.41 | 0.41 | 0.43 | |
Debt to Capital (including Operating Lease Liability), Industry | ||||||
Health Care | — | 0.46 | 0.44 | 0.46 | 0.49 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
Debt to capital (including operating lease liability) = Total debt (including operating lease liability) ÷ Total capital (including operating lease liability)
= 146,000 ÷ 16,579,700 = 0.01
2 Click competitor name to see calculations.
Solvency ratio | Description | The company |
---|---|---|
Debt to capital ratio (including operating lease liability) | A solvency ratio calculated as total debt (including operating lease liability) divided by total debt (including operating lease liability) plus shareholders’ equity. | Intuitive Surgical Inc. debt to capital ratio (including operating lease liability) improved from 2022 to 2023 but then deteriorated significantly from 2023 to 2024. |
Debt to Assets
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Selected Financial Data (US$ in thousands) | ||||||
Total debt | —) | —) | —) | —) | —) | |
Total assets | 18,743,200) | 15,441,500) | 12,974,000) | 13,555,000) | 11,168,900) | |
Solvency Ratio | ||||||
Debt to assets1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Benchmarks | ||||||
Debt to Assets, Competitors2 | ||||||
Abbott Laboratories | — | 0.20 | 0.23 | 0.24 | 0.26 | |
Cigna Group | — | 0.20 | 0.22 | 0.22 | 0.21 | |
CVS Health Corp. | — | 0.25 | 0.23 | 0.24 | 0.28 | |
Elevance Health Inc. | — | 0.23 | 0.23 | 0.24 | 0.23 | |
Medtronic PLC | 0.28 | 0.27 | 0.27 | 0.28 | 0.27 | |
UnitedHealth Group Inc. | — | 0.23 | 0.23 | 0.22 | 0.22 | |
Debt to Assets, Sector | ||||||
Health Care Equipment & Services | — | 0.23 | 0.23 | 0.23 | 0.24 | |
Debt to Assets, Industry | ||||||
Health Care | — | 0.29 | 0.27 | 0.28 | 0.31 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
Debt to assets = Total debt ÷ Total assets
= 0 ÷ 18,743,200 = 0.00
2 Click competitor name to see calculations.
Solvency ratio | Description | The company |
---|---|---|
Debt to assets ratio | A solvency ratio calculated as total debt divided by total assets. |
Debt to Assets (including Operating Lease Liability)
Intuitive Surgical Inc., debt to assets (including operating lease liability) calculation, comparison to benchmarks
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Selected Financial Data (US$ in thousands) | ||||||
Total debt | —) | —) | —) | —) | —) | |
Operating lease liabilities (reported as Other accrued liabilities) | 33,500) | 25,300) | 24,200) | 20,400) | 21,900) | |
Operating lease liabilities (reported as Other long-term liabilities) | 112,500) | 64,500) | 69,600) | 66,600) | 58,000) | |
Total debt (including operating lease liability) | 146,000) | 89,800) | 93,800) | 87,000) | 79,900) | |
Total assets | 18,743,200) | 15,441,500) | 12,974,000) | 13,555,000) | 11,168,900) | |
Solvency Ratio | ||||||
Debt to assets (including operating lease liability)1 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Benchmarks | ||||||
Debt to Assets (including Operating Lease Liability), Competitors2 | ||||||
Abbott Laboratories | — | 0.22 | 0.24 | 0.26 | 0.27 | |
Cigna Group | — | 0.21 | 0.22 | 0.22 | 0.22 | |
CVS Health Corp. | — | 0.32 | 0.31 | 0.33 | 0.37 | |
Elevance Health Inc. | — | 0.24 | 0.24 | 0.25 | 0.24 | |
Medtronic PLC | 0.29 | 0.28 | 0.27 | 0.29 | 0.28 | |
UnitedHealth Group Inc. | — | 0.25 | 0.25 | 0.24 | 0.24 | |
Debt to Assets (including Operating Lease Liability), Sector | ||||||
Health Care Equipment & Services | — | 0.25 | 0.26 | 0.26 | 0.28 | |
Debt to Assets (including Operating Lease Liability), Industry | ||||||
Health Care | — | 0.31 | 0.29 | 0.30 | 0.33 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
Debt to assets (including operating lease liability) = Total debt (including operating lease liability) ÷ Total assets
= 146,000 ÷ 18,743,200 = 0.01
2 Click competitor name to see calculations.
Solvency ratio | Description | The company |
---|---|---|
Debt to assets ratio (including operating lease liability) | A solvency ratio calculated as total debt (including operating lease liability) divided by total assets. | Intuitive Surgical Inc. debt to assets ratio (including operating lease liability) improved from 2022 to 2023 but then deteriorated significantly from 2023 to 2024. |
Financial Leverage
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Selected Financial Data (US$ in thousands) | ||||||
Total assets | 18,743,200) | 15,441,500) | 12,974,000) | 13,555,000) | 11,168,900) | |
Total Intuitive Surgical, Inc. stockholders’ equity | 16,433,700) | 13,307,600) | 11,041,900) | 11,901,100) | 9,731,500) | |
Solvency Ratio | ||||||
Financial leverage1 | 1.14 | 1.16 | 1.17 | 1.14 | 1.15 | |
Benchmarks | ||||||
Financial Leverage, Competitors2 | ||||||
Abbott Laboratories | — | 1.90 | 2.03 | 2.10 | 2.21 | |
Cigna Group | — | 3.30 | 3.21 | 3.29 | 3.09 | |
CVS Health Corp. | — | 3.27 | 3.21 | 3.10 | 3.32 | |
Elevance Health Inc. | — | 2.77 | 2.83 | 2.70 | 2.61 | |
Medtronic PLC | 1.79 | 1.77 | 1.73 | 1.81 | 1.79 | |
UnitedHealth Group Inc. | — | 3.08 | 3.16 | 2.96 | 3.01 | |
Financial Leverage, Sector | ||||||
Health Care Equipment & Services | — | 2.72 | 2.72 | 2.67 | 2.71 | |
Financial Leverage, Industry | ||||||
Health Care | — | 2.79 | 2.67 | 2.77 | 2.94 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
Financial leverage = Total assets ÷ Total Intuitive Surgical, Inc. stockholders’ equity
= 18,743,200 ÷ 16,433,700 = 1.14
2 Click competitor name to see calculations.
Solvency ratio | Description | The company |
---|---|---|
Financial leverage ratio | A solvency ratio calculated as total assets divided by total shareholders’ equity. | Intuitive Surgical Inc. financial leverage ratio decreased from 2022 to 2023 and from 2023 to 2024. |
Interest Coverage
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Selected Financial Data (US$ in thousands) | ||||||
Net income attributable to Intuitive Surgical, Inc. | 2,322,600) | 1,798,000) | 1,322,300) | 1,704,600) | 1,060,600) | |
Add: Net income attributable to noncontrolling interest | 14,900) | 19,300) | 22,100) | 23,500) | 6,200) | |
Add: Income tax expense | 336,300) | 141,600) | 262,400) | 162,200) | 140,200) | |
Add: Interest expense | —) | —) | —) | —) | —) | |
Earnings before interest and tax (EBIT) | 2,673,800) | 1,958,900) | 1,606,800) | 1,890,300) | 1,207,000) | |
Solvency Ratio | ||||||
Interest coverage1 | — | — | — | — | — | |
Benchmarks | ||||||
Interest Coverage, Competitors2 | ||||||
Abbott Laboratories | — | 11.46 | 15.89 | 16.41 | 10.10 | |
Cigna Group | — | 4.94 | 7.43 | 6.22 | 8.76 | |
CVS Health Corp. | — | 5.20 | 3.46 | 5.16 | 4.36 | |
Elevance Health Inc. | — | 8.49 | 10.13 | 10.93 | 8.96 | |
Medtronic PLC | 7.73 | 9.43 | 10.98 | 5.21 | 4.71 | |
UnitedHealth Group Inc. | — | 9.97 | 13.59 | 14.44 | 13.47 | |
Interest Coverage, Sector | ||||||
Health Care Equipment & Services | — | 8.03 | 9.31 | 8.96 | 7.89 | |
Interest Coverage, Industry | ||||||
Health Care | — | 7.09 | 12.71 | 12.24 | 7.71 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
Interest coverage = EBIT ÷ Interest expense
= 2,673,800 ÷ 0 = —
2 Click competitor name to see calculations.
Fixed Charge Coverage
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Selected Financial Data (US$ in thousands) | ||||||
Net income attributable to Intuitive Surgical, Inc. | 2,322,600) | 1,798,000) | 1,322,300) | 1,704,600) | 1,060,600) | |
Add: Net income attributable to noncontrolling interest | 14,900) | 19,300) | 22,100) | 23,500) | 6,200) | |
Add: Income tax expense | 336,300) | 141,600) | 262,400) | 162,200) | 140,200) | |
Add: Interest expense | —) | —) | —) | —) | —) | |
Earnings before interest and tax (EBIT) | 2,673,800) | 1,958,900) | 1,606,800) | 1,890,300) | 1,207,000) | |
Add: Operating lease expense | 33,900) | 26,800) | 25,700) | 20,400) | 21,000) | |
Earnings before fixed charges and tax | 2,707,700) | 1,985,700) | 1,632,500) | 1,910,700) | 1,228,000) | |
Interest expense | —) | —) | —) | —) | —) | |
Operating lease expense | 33,900) | 26,800) | 25,700) | 20,400) | 21,000) | |
Fixed charges | 33,900) | 26,800) | 25,700) | 20,400) | 21,000) | |
Solvency Ratio | ||||||
Fixed charge coverage1 | 79.87 | 74.09 | 63.52 | 93.66 | 58.48 | |
Benchmarks | ||||||
Fixed Charge Coverage, Competitors2 | ||||||
Abbott Laboratories | — | 7.71 | 10.10 | 10.21 | 6.68 | |
Cigna Group | — | 4.64 | 6.87 | 5.61 | 7.84 | |
CVS Health Corp. | — | 3.15 | 2.16 | 3.03 | 2.75 | |
Elevance Health Inc. | — | 7.51 | 8.82 | 8.48 | 6.10 | |
Medtronic PLC | 5.88 | 6.90 | 7.79 | 4.31 | 3.98 | |
UnitedHealth Group Inc. | — | 7.27 | 8.77 | 8.80 | 8.51 | |
Fixed Charge Coverage, Sector | ||||||
Health Care Equipment & Services | — | 5.67 | 6.11 | 5.87 | 5.31 | |
Fixed Charge Coverage, Industry | ||||||
Health Care | — | 5.52 | 9.02 | 8.67 | 5.70 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
Fixed charge coverage = Earnings before fixed charges and tax ÷ Fixed charges
= 2,707,700 ÷ 33,900 = 79.87
2 Click competitor name to see calculations.
Solvency ratio | Description | The company |
---|---|---|
Fixed charge coverage ratio | A solvency ratio calculated as earnings before fixed charges and tax divided by fixed charges. | Intuitive Surgical Inc. fixed charge coverage ratio improved from 2022 to 2023 and from 2023 to 2024. |